ArticleJournal of diabetes investigation2026
Serum CTRP3 and CysC correlate with glucose, lipid, and bone metabolism in elderly patients with type 2 diabetes mellitus complicated with osteoporosis.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study analyzed the correlation between serum C1q/TNF-related protein 3 (CTRP3) and cystatin C (CysC) and glucose-lipid metabolism, bone mineral density (BMD), and bone metabolism markers in elderly patients with type 2 diabetes mellitus (T2DM) complicated with osteoporosis (OP).
methodsA retrospective analysis was conducted on 235 patients with T2DM admitted to Taizhou Municipal Hospital between January 2021 and June 2024. They were categorized into the T2DM group (n = 131) and the T2DM + OP group (n = 104). A healthy control group (n = 95) was established, comprising elderly individuals without diabetes or OP. Serum CTRP3 and CysC were measured. The correlation between serum CTRP3 and CysC levels and relevant metabolism markers and BMD was analyzed. The diagnostic values of serum CTRP3 and CysC were assessed, as well as their role in T2DM + OP.
resultsSerum CTRP3 was lower and CysC was higher in the T2DM + OP group. Serum CTRP3 and CysC levels in the T2DM + OP group were correlated with some indicators of glucose-lipid metabolism and bone metabolism and BMD. The area under the curve (AUC) values of serum CTRP3 and CysC levels in distinguishing T2DM + OP were 0.719 and 0.702 (sensitivity: 60.58%; 61.54%, specificity: 74.05%; 74.05%), respectively, with their combination showing better performance (AUC: 0.773, sensitivity: 76.92%, specificity: 64.89%). Elevated serum CysC (OR: 1.422, 95%CI: 1.161-1.742) and CTRP3 (OR: 0.960, 95%CI: 0.943-0.976) were independent risk and protective factors for T2DM + OP in elderly patients, respectively (all P < 0.05).
conclusionCTRP3 and CysC combined detection helps distinguish OP in elderly patients with T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.